Clinical trial • Phase I • Oncology

Sigvotatug Vedotin for Esophageal cancer|Pancreatic cancer|Skin cancer|Gastric cancer|Head and neck cancer|Ovarian cancer|Non-small cell lung cancer|Cervical cancer|Breast cancer|Bladder cancer

Phase I trial of Sigvotatug Vedotin for Esophageal cancer|Pancreatic cancer|Skin cancer|Gastric cancer|Head and neck cancer|Ovarian cancer|Non-small cell…

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Esophageal cancer|Pancreatic cancer|Skin cancer|Gastric cancer|Head and neck cancer|Ovarian cancer|Non-small cell lung cancer|Cervical cancer|Breast cancer|Bladder cancer
Trial Stage
Phase I

Key dates

Initial CTIS Submission Date
30-04-2024
First CTIS Authorization Date
20-05-2024

Trial design

Phase I trial across 15 sites in France, Spain.

Target Sample Size
768

Recruitment

Planned Sample Size
768
Recruitment Window Months
84

Geography

Total Number Of Sites
15
Total Number Of Participants
238

France

Earliest CTIS Part Ii Submission Date
09-04-2024
Latest Decision Or Authorization Date
25-03-2026
Processing Time Days
715
Number Of Sites
5
Number Of Participants
150

Sites

Site Name
Centre Hospitalier Universitaire D'Angers
Department Name
Service de Pneumologie
Principal Investigator Name
Youssef Oulkhouir
Principal Investigator Email
youssef.Oulkhouir@chu-angers.fr
Contact Person Name
Youssef Oulkhouir
Site Name
Centre Hospitalier Universitaire De Poitiers
Department Name
Service d'Oncologie Méicale
Principal Investigator Name
Nicolas Isambert
Principal Investigator Email
nicolas.isambert@chu-poitiers.fr
Contact Person Name
Nicolas Isambert
Site Name
Centre Antoine Lacassagne
Department Name
Département d'Oncologie Médicale
Principal Investigator Name
Esma Saada-Bouzid
Principal Investigator Email
esma.saada-bouzid@nice.unicancer.fr
Contact Person Name
Esma Saada-Bouzid
Site Name
Institut De Cancerologie De Lorraine
Department Name
Département d'Oncologie Médicale
Principal Investigator Name
Aurélien Lambert
Principal Investigator Email
a.lambert@nancy.unicancer.fr
Contact Person Name
Aurélien Lambert
Contact Person Email
a.lambert@nancy.unicancer.fr
Site Name
Institut Gustave Roussy
Department Name
Département d’Innovation Thérapeutique et d’Essais, Précoces (DITEP)
Principal Investigator Name
Antoine Hollebecque
Principal Investigator Email
antoine.hollebecque@gustaveroussy.fr
Contact Person Name
Antoine Hollebecque

Spain

Earliest CTIS Part Ii Submission Date
09-04-2024
Latest Decision Or Authorization Date
23-03-2026
Processing Time Days
713
Number Of Sites
10
Number Of Participants
88

Sites

Site Name
Hospital De Jerez De La Frontera
Department Name
UGC Oncologia Medica
Principal Investigator Name
Jesus Corral
Principal Investigator Email
jesuscorraljaime@hotmail.com
Contact Person Name
Jesus Corral
Contact Person Email
jesuscorraljaime@hotmail.com
Site Name
Hospital Universitario Hm Sanchinarro
Department Name
Unidad de Ensayos Clínicos START Madrid # CIOCC
Principal Investigator Name
Emiliano Calvo
Principal Investigator Email
emiliano.calvo@startmadrid.com
Contact Person Name
Emiliano Calvo
Contact Person Email
emiliano.calvo@startmadrid.com
Site Name
Hospital Quironsalud Malaga
Department Name
Oncología Médica
Principal Investigator Name
Manuel Cobo
Principal Investigator Email
manuelcobodols@yahoo.es
Contact Person Name
Manuel Cobo
Contact Person Email
manuelcobodols@yahoo.es
Site Name
Hospital Quironsalud Barcelona
Department Name
Oncología Médica. Unidad NEXT Oncology
Principal Investigator Name
Omar Saavedra
Principal Investigator Email
osaavedra@nextoncology.eu
Contact Person Name
Omar Saavedra
Contact Person Email
osaavedra@nextoncology.eu
Site Name
Hospital Hm Nou Delfos
Department Name
Unidad de Ensayos Clínicos START Barcelona
Principal Investigator Name
Tatiana Hernandez
Principal Investigator Email
Tatiana.hernandez@start-barcelona.com
Contact Person Name
Tatiana Hernandez
Site Name
Hospital General Universitario De Elche
Department Name
Servicio de Oncología Médica
Principal Investigator Name
Javier David Benitez-Fuentes
Principal Investigator Email
javierdavidbenitezfuentes@gmail.com
Contact Person Name
Javier David Benitez-Fuentes
Site Name
Vall D Hebron Institute Of Oncology
Department Name
Unidad Investigacion Terapia Molecular - VHIO
Principal Investigator Name
Elena Garralda
Principal Investigator Email
egarralda@vhio.net
Contact Person Name
Elena Garralda
Contact Person Email
egarralda@vhio.net
Site Name
Hospital Universitario Ramon Y Cajal
Department Name
Servicio de Oncología Médica
Principal Investigator Name
Federico Longo
Principal Investigator Email
federico.longo@salud.madrid.org
Contact Person Name
Federico Longo
Site Name
Hospital Universitario 12 De Octubre
Department Name
Oncologia
Principal Investigator Name
Luis Paz-Ares Rodriguez
Principal Investigator Email
lpazaresr@seom.org
Contact Person Name
Luis Paz-Ares Rodriguez
Contact Person Email
lpazaresr@seom.org
Site Name
Hospital Universitario Marques De Valdecilla
Department Name
Servicio de Oncologia
Principal Investigator Name
Fernando Rivera
Principal Investigator Email
Fernando.rivera@scsalud.es
Contact Person Name
Fernando Rivera
Contact Person Email
Fernando.rivera@scsalud.es

Sponsor

Primary sponsor

Full Name
Seagen Inc.
Organisation Type
Pharmaceutical company
Country Of Registered Address
United States

Investigational products

Investigational Product Name
Sigvotatug Vedotin

Related trials

Other published trials that may interest you.